Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRTX | APLS | ADMA | ||
| Company | Mirati Therapeutics | Apellis Pharmaceuticals Inc | Adma Biologics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 58.86 | 33.16 | 17.16 | ||
| High | 58.99 | 34.27 | 17.96 | ||
| Low | 58.54 | 32.89 | 17.08 | ||
| Last | 58.70 | 33.21 | 17.40 | ||
| Change | -0.10 | +0.07 | -0.50 | ||
| % Change | -0.17% | +0.21% | -2.79% | ||
| Volume | 20,994,400 | 3,733,200 | 6,941,500 | ||
| 20-Day Average Volume | 2,385,220 | 3,212,990 | 2,772,595 | ||
| Previous Close | 58.80 | 33.14 | 17.90 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 58.94 | 33.63 | 19.54 | ||
| 20-Day Raw Stochastic | 17.39% | 68.66% | 6.26% | ||
| 20-Day Relative Strength | 61.06% | 54.11% | 41.45% | ||
| Weighted Alpha | -3.70 | -40.95 | +175.06 | ||
| Today's Opinion | 88% Buy | 24% Sell | 40% Buy | ||
| Previous Opinion | 88% Buy | 24% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.98% since 01/12/24 | +0.06% since 12/13/24 | -6.40% since 12/13/24 | ||
| Low | 58.54 on 01/22/24 | 32.71 on 12/16/24 | 17.08 on 12/20/24 | ||
| High | 59.27 on 01/16/24 | 35.71 on 12/18/24 | 19.19 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -0.41% since 12/22/23 | +20.81% since 11/20/24 | -18.58% since 11/20/24 | ||
| Low | 58.54 on 01/22/24 | 26.62 on 11/21/24 | 17.08 on 12/20/24 | ||
| High | 59.46 on 01/12/24 | 35.72 on 12/09/24 | 22.19 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | +5.42% since 10/20/23 | +2.15% since 09/20/24 | -12.91% since 09/20/24 | ||
| Low | 55.14 on 10/27/23 | 24.34 on 11/05/24 | 15.33 on 10/21/24 | ||
| High | 59.46 on 01/12/24 | 35.72 on 12/09/24 | 23.64 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +87.48% since 07/21/23 | -16.41% since 06/20/24 | +62.46% since 06/20/24 | ||
| Low | 27.30 on 08/08/23 | 24.34 on 11/05/24 | 10.21 on 08/05/24 | ||
| High | 64.41 on 10/06/23 | 42.47 on 07/16/24 | 23.64 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,117,688 | 4,131,091 | 4,113,186 | ||
| Shares Outstanding, K | 70,148 | 124,393 | 236,390 | ||
| Annual Sales | 12,440,000 | 396,590,000 | 258,220,000 | ||
| Annual Net Income | -740,870,000 | -528,630,000 | -28,240,000 | ||
| Last Quarter Sales | 16,400,000 | 196,830,000 | 119,840,000 | ||
| Last Quarter Net Income | -161,900,000 | -57,450,000 | 35,910,000 | ||
| 60-Month Beta | 0.77 | 0.94 | 0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.49 on 11/06/23 | -0.46 on 11/05/24 | 0.15 on 11/07/24 | ||
| Latest Earnings Date | 02/27/24 | 11/05/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 44.75 | ||